Federal Register of Legislation - Australian Government

Primary content

This instrument makes amendments to determine that certain phases of clinical trials for an unapproved therapeutic good are core R&D activities for the purposes of exercising its power or performing its duty to make a finding pursuant to the Industry Research and Development Act 1986.
Administered by: Industry, Science, Energy and Resources
Registered 29 Jun 2022
Date of repeal 01 Jul 2022
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Help with file formats Help with file formats
Notifiable Instrument
 
F2022N00150 : Authoritative PDF Document : 0.7MB Primary Document Icon F2022N00150 : ZIP Document : 74KB
8 pages